NAS
MEDP icon

Nykredit A/S’s Medpace MEDP Stock Holding History

Nykredit A/S’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$356K Buy
+672
New +$310K ﹤0.01% 793

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nykredit A/S's MEDP Position: Q2 2026 in Review

Nykredit A/S opened a new position in Medpace (MEDP) in Q2 2026: 672 shares worth $356K. The stake represents ﹤0.01% of the portfolio and ranks #793 among its holdings.

551 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Nykredit A/S held 672 shares of Medpace worth $356K as of Q2 2026.
  • Medpace was a new Nykredit A/S position in Q2 2026.
  • Medpace made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #793 holding.
  • 551 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.